Author

Gentry G. King

Observed name: Gentry King

Institutions: University of Washington, Fred Hutch Cancer Center

Observed institutions: University of Washington, Fred Hutch Cancer Center, University of Colorado Anschutz, University of Colorado Denver

OpenAlex ID: A5065249685

Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung

2017 · Sinead A. Noonan, Tejas Patil, et al. · Journal of Thoracic Oncology · 25

Treatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World

2022 · Gentry King, Stacie Ittershagen, et al. · Advances in Therapy · 20

Successful treatment of disseminated Rosai-Dorfman disease with siltuximab

2018 · Hannah Lee, Gentry King, et al. · Haematologica · 8

High incidence of prolonged rectal bleeding and advanced stage cancer in early-onset colorectal cancer patients

2020 · Gurprataap Singh Sandhu, Rebekah Anders, et al. · Colorectal Cancer · 7

Finding a role for cancer vaccines in pancreatic cancer: a model of resilience

2021 · Gentry King, Steven Green, et al. · HepatoBiliary Surgery and Nutrition · 5

Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic Adenocarcinoma

2023 · Andrew L. Coveler, Venu G. Pillarisetty, et al. · Pancreas · 3

Works count: 6

Citation count: 68

H-index: 5

I10-index: 2